Fluorothymidine PET/CT in neurolymphomatosis

Clin Nucl Med. 2015 May;40(5):e290-2. doi: 10.1097/RLU.0000000000000632.

Abstract

Neurolymphomatosis, a rare extranodal lymphoma, may involve the cranial nerves, peripheral nerves, spinal nerve roots, or nerve plexus. F-FDG PET/CT however shows increased FDG uptake in the nerves but is not specific for malignancy. We report a patient with neurolymphomatosis who underwent F-FDG PET/CT and F-fluorothymidine PET/CT where both the scans showed increased tracer uptake in the right sciatic nerve, proven later as neurolymphomatosis on nerve biopsy. Furthermore, the F-FDG avid mediastinal lymph nodes did not show F-fluorothymidine avidity, suggesting an inflammatory etiology.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Biopsy
  • Dideoxynucleosides*
  • Fluorodeoxyglucose F18
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / diagnosis*
  • Lymphoma, Large B-Cell, Diffuse / pathology*
  • Male
  • Marek Disease / diagnostic imaging*
  • Middle Aged
  • Multimodal Imaging
  • Peripheral Nervous System Neoplasms / diagnosis*
  • Peripheral Nervous System Neoplasms / pathology*
  • Positron-Emission Tomography*
  • Radiopharmaceuticals*
  • Sciatic Neuropathy / diagnosis*
  • Sciatic Neuropathy / pathology*
  • Tomography, X-Ray Computed*

Substances

  • Dideoxynucleosides
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • alovudine